Search Results 1361-1370 of 19354 for hemoglobin

1. A Study to Evaluate UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma - Mayo Clinic

   Hemoglobin ≥ 9 g/dL; or ≥ 5.6 mmol/L. Renal. Creatinine ≤ 1.5 x upper limit of normal (ULN). Hepatic. Total bilirubin ≤1.5 x ULN; or; Direct bilirubin ...

2. Diabetes treatment: Medications for type 2 diabetes - Mayo Clinic

   Confused by all the treatment choices for type 2 diabetes? Use this guide to better understand the medicines available to help control blood sugar.

3. Pilot Study Of Duodenal Mucosal RF Vapor Ablation In US Subjects With Type-2 Diabetes Mellitus - Mayo Clinic

   Persistent anemia, defined as hemoglobin <10g/dl. Significant cardiovascular disease, including known history of valvular disease, or myocardial infarction ...

4. 5-strain Probiotic Formulation in Hormone Receptor-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL; Creatinine ≤ 2 x ULN; SGOT (AST) ≤ 2 x ULN; Albumin ≥ 3 g/dL. Willing and able to provide research stool and blood samples. Negative ...

5. Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial - Mayo Clinic

   * Hemoglobin \>= 8.0 g/dL. * Total bilirubin =\< 1.5 x upper limit of normal (ULN) (obtained =\< 14 days prior to registration). * Alanine transaminase (ALT) ...

6. Therapeutic Plasma Exchange With Enfortumab Vedotin And Pembrolizumab For Treatment Of Bladder Cancers - Mayo Clinic

   * Hemoglobin \> 7.0 g/dL (obtained ≤ 30 days prior to registration) * Platelet count ≥ 75,000/mm\^3 (obtained ≤ 30 days prior to registration) * Alanine ...

7. Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™ - Mayo Clinic

   Bone marrow: platelets ≥75 x 109/L, absolute neutrophil count (ANC) ≥1.5 x 109/L, hemoglobin ≥10 g/dL. (Platelets ≥50 x 109/L, ANC ≥1.0 x 109/L, hemoglobin ...

8. Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma - Mayo Clinic

   Hemoglobin ≥ 8 g/dL; Total bilirubin ≤ 1.5 times institutional upper limit of normal (ULN); Patients with relapsed multiple myeloma who have already ...

9. P1101 in Treating Patients With Myelofibrosis - Mayo Clinic

   Hemoglobin < 10 g/dL. Confirmed diagnosis of myelofibrosis (primary myelofibrosis or myelofibrosis secondary to essential thrombocythemia or polycythemia ...

10. CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin - Mayo Clinic

    Hemoglobin > 9 g/dl; Absolute neutrophil count ≥ 1,500/mcL; Platelets ≥ 100,000/mcL; Total bilirubin < 1.5 X ULN; AST(SGOT)/ALT(SGPT) ≤3 X ULN (including ...